1.96
price up icon12.00%   0.21
after-market アフターアワーズ: 1.82 -0.14 -7.14%
loading

Regulus Therapeutics Inc (RGLS) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
-
- - - -
Operating Expenses
6.34%
8.826
8.30 8.125 7.315 7.369
Interest Income/Expense
28.95%
0.081
0.114 0.137 0.168 0.185
Operating Income/Loss
6.34%
-8.826
-8.30 -8.125 -7.315 -7.369
Income/Loss From Continuing Operations Before Tax
5.06%
-8.469
-8.061 -7.824 -7.012 -7.139
Income/Loss From Continuing Operations After Tax
5.06%
-8.469
-8.061 -7.824 -7.013 -7.139
Net Income/Loss
5.06%
-8.469
-8.061 -7.824 -7.013 -7.139
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
6,661%
28.75
0.4252 19.63 19.10 16.84
Diluted Average Shares
6,661%
28.75
0.4252 19.63 19.10 16.84
Basic Earnings Per Share
110.47%
-0.29
2.77 -0.40 -0.37 -0.42
Diluted Earnings Per Share
110.47%
-0.29
2.77 -0.40 -0.37 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
大文字化:     |  ボリューム (24 時間):